Highlights
- Rapid diagnostic tests or RTDs usually use a needle prick for diagnosing malaria are time consuming A blood-free microneedle patch test has been developed for detecting malaria that delivers results within just 20 minutes
- The microneedle-based patch extracts the protein present in dermal interstitial fluid in the skin
- This protein is a biomarker for various infectious diseases like malaria and now, even COVID-19
A microneedle patch will help in the rapid diagnosis of malaria without the need for drawing blood. Researchers from Rice University, who developed the microneedle-based patch test, say that malaria testing could now become as simple as applying a bandage.
The self-contained tests deliver results in 20 minutes and require the use of no special equipment or medical expertise. Usually, many infectious diseases are tested using time-consuming, laborious, and expensive laboratory-based microscopy and molecular assays that require the help of trained medical professionals and equipment. These methods also pose the risk of infection or accidental disease transmission.
Listen to this article
0:00/0:00
Malaria - Protection Strategies
Malaria is a dangerous disease with lethal consequences that requires protective measures for prevention and control of malaria in endemic regions of the world.
Malaria is a dangerous disease with lethal consequences that requires protective measures for prevention and control of malaria in endemic regions of the world.
Advertisement
‘The microneedle-based skin patch test for malaria uses one strip of hollow microneedle array and another antibody strip. It is a minimally invasive, bloodless sampling of interstitial fluid on the skin surface.’
Tweet it Now
The findings are detailed in the Nature journal Microsystems and Nanoengineering.
For the procedure, proteins that are present in dermal interstitial fluid are extracted. This fluid is a biomarker for various diseases like malaria and can be used for rapid testing.
![Malaria]( "Malaria")
People usually recognize this fluid as blisters, but this fluid surrounds all of the cells in the skin.
According to Peter Lillehoj of Rice's Brown School of Engineering, the disposable patches could be programmed to detect other diseases, potentially including COVID-19.
"In this paper, we focus on malaria detection because this project was funded by the Bill and Melinda Gates Foundation, and it's a big priority for them," said Lillehoj, who joined Rice in January as an associate professor of mechanical engineering. "But we can adapt this technology to detect other diseases for which biomarkers appear in interstitial fluid."
The self-contained test was developed by Lillehoj and lead author Xue Jian.
The needles are 375 microns wide and 750 microns long enough to reach the fluid in the skin, which is around 800 to 100 microns thick. Needles are sharp enough to penetrate the skin.
The needles are attracted to water, and this helps the interstitial fluid to flow in through the test strip.
The antibodies react when they sense protein biomarkers for malaria. If the test is positive, two readout lines on the strip's exposed surface turns red, and if the test is negative, only one line turns red.
The device can be removed like any bandage on the completion of the test.
This experiment is the first to combine both microneedles and antibody test strips into a simple, inexpensive package that can be used at the time of need. The test is particularly useful in developing countries where finger-prick blood sampling and the availability of trained medical personnel to diagnose samples may be challenging.
Lastly, the researchers claim to have self-tested the patch and found it to be pain-free, and user-friendly, especially for children. Lillehoj said "We didn't intend for it to look like a bandage. We started with a rectangular shape and then just rounded the edges to make it a little more presentable. We didn't plan for that, but perhaps it makes the patch more relatable to the general public."
Reference:
Source: Medindia
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.
Advertisement
People usually recognize this fluid as blisters, but this fluid surrounds all of the cells in the skin.
According to Peter Lillehoj of Rice's Brown School of Engineering, the disposable patches could be programmed to detect other diseases, potentially including COVID-19.
"In this paper, we focus on malaria detection because this project was funded by the Bill and Melinda Gates Foundation, and it's a big priority for them," said Lillehoj, who joined Rice in January as an associate professor of mechanical engineering. "But we can adapt this technology to detect other diseases for which biomarkers appear in interstitial fluid."
The self-contained test was developed by Lillehoj and lead author Xue Jian.
How the Patch Works
The sticky patch is made up of sixteen hollow microneedles in a 4-by-4 array on one side, along with an antibody-based lateral-flow test strip on the other.The needles are 375 microns wide and 750 microns long enough to reach the fluid in the skin, which is around 800 to 100 microns thick. Needles are sharp enough to penetrate the skin.
The needles are attracted to water, and this helps the interstitial fluid to flow in through the test strip.
The antibodies react when they sense protein biomarkers for malaria. If the test is positive, two readout lines on the strip's exposed surface turns red, and if the test is negative, only one line turns red.
The device can be removed like any bandage on the completion of the test.
This experiment is the first to combine both microneedles and antibody test strips into a simple, inexpensive package that can be used at the time of need. The test is particularly useful in developing countries where finger-prick blood sampling and the availability of trained medical personnel to diagnose samples may be challenging.
Lastly, the researchers claim to have self-tested the patch and found it to be pain-free, and user-friendly, especially for children. Lillehoj said "We didn't intend for it to look like a bandage. We started with a rectangular shape and then just rounded the edges to make it a little more presentable. We didn't plan for that, but perhaps it makes the patch more relatable to the general public."
Reference:
- Microneedle-based skin patch for blood-free rapid diagnostic testing - (https://www.nature.com/articles/s41378-020-00206-1)
Source: Medindia
People With Blood Group A Prone to Malaria
Blood cells of those with blood group A produce a protein which forms clumps and increases the severity of the disease.
Blood cells of those with blood group A produce a protein which forms clumps and increases the severity of the disease.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Health In Focus
Explore how gut microbes and a new therapy called fecal microbiota transplant may transform the treatment of inflammatory bowel diseases (IBD).
Kerala passes amendment to its hospital protection act to safeguard doctors from violence, imposing stricter penalties. This ensures safety for medical professionals.
Exploring how an Artificial Intelligence system could be held liable for legal damages in case of adverse patient outcomes.
Tirazepatide is a brand-new drug that has a combined action on both diabetes and obesity is often recommended for weight loss due to its effective action.
Understanding how the National Medical Device Policy puts forth objectives and strategies to govern, develop and set standards for the industry.